FABP2 and ischemia: Specific bowel biomarkers such as plasma citrulline, an amino acid reflecting functional enterocyte mass, and intestinal-fatty acid binding protein (I-FABP), a cytosolic protein specific to small bowel released in case of ischemia, have been proposed but their performance remains to be evaluated especially in NOMI setting [19–21].